This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1974 Jul;31(1):55-6.

doi: 10.1001/archneur.1974.00490370081013.

Hypothalamic releasing factors and Parkinson disease

T N Chase, A C Woods, M A Lipton, C E Morris

PMID: 4209275
DOI: 10.1001/archneur.1974.00490370081013

Comparative Study

Hypothalamic releasing factors and Parkinson disease

T N Chase et al. Arch Neurol. 1974 Jul.

. 1974 Jul;31(1):55-6.

doi: 10.1001/archneur.1974.00490370081013.

Authors

T N Chase, A C Woods, M A Lipton, C E Morris

PMID: 4209275
DOI: 10.1001/archneur.1974.00490370081013

No abstract available

PubMed Disclaimer

Similar articles

Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
Castensson S, Sievertsson H, Lindeke B, Sum CY. Castensson S, et al. FEBS Lett. 1974 Aug 15;44(1):101-5. doi: 10.1016/0014-5793(74)80315-7. FEBS Lett. 1974. PMID: 4212370 No abstract available.
Melanocyte-stimulating hormone and parkinsonism: the role of hypothalamic releasing factors.
Sandler M, Goodwin BL, Leask BG, Ruthven CR. Sandler M, et al. Lancet. 1973 Mar 17;1(7803):612. doi: 10.1016/s0140-6736(73)90765-4. Lancet. 1973. PMID: 4120682 No abstract available.
Melanocyte-stimulating hormone and the hypothalamic hormone which inhibits its release.
Kastin AJ, Barbeau A, Ehrensing RH, Plotnikoff NP, Schally AV. Kastin AJ, et al. Adv Neurol. 1974;5:225-9. Adv Neurol. 1974. PMID: 4216256 No abstract available.
Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
Vale W, Grant G, Guillemin R. Vale W, et al. Front Neuroendocrinol. 1973;0(0):375-413. Front Neuroendocrinol. 1973. PMID: 4369859 Review. No abstract available.
Hypothalamic releasing factors.
Burgus R, Guillemin R. Burgus R, et al. Annu Rev Biochem. 1970;39:499-526. doi: 10.1146/annurev.bi.39.070170.002435. Annu Rev Biochem. 1970. PMID: 4320674 Review. No abstract available.

See all similar articles

Cited by

Endocrine aspects of bromocriptine therapy in Parkinsonism.
Shaw KM, Lees AJ, Franks S, Daggett P, Thompson BD, Stern GM. Shaw KM, et al. J Neural Transm. 1978;43(2):153-60. doi: 10.1007/BF01579074. J Neural Transm. 1978. PMID: 104006
Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.
Caraceni T, Parati EA, Girotti F, Celano I, Frigerio C, Cocchi D, Müller EE. Caraceni T, et al. Psychopharmacology (Berl). 1979 Jun 21;63(3):217-22. doi: 10.1007/BF00433553. Psychopharmacology (Berl). 1979. PMID: 39308
Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.
Crowley TJ, Hydinger M. Crowley TJ, et al. Psychopharmacology (Berl). 1977 Jul 18;53(2):205-6. doi: 10.1007/BF00426494. Psychopharmacology (Berl). 1977. PMID: 19803

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database